Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc. (DRMA) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 51 transactions totaling $97.6K, demonstrating a bullish sentiment with $97.6K in net insider flow. The most recent transaction on Dec 23, 2025 involved a transaction of 490,196 shares valued at $0.
DRMA Insider Activity Summary
Who Is Buying DRMA Stock?
No significant insider buying has been recorded for DRMA in the recent period.
Who Is Selling DRMA Stock?
No significant insider selling has been recorded for DRMA in the recent period.
Is Dermata Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for DRMA is bullish with an Insider Alignment Score of 100/100 and a net flow of $97.6K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
DRMA Frequently Asked Questions
Understanding DRMA Insider Activity
Insider trading at Dermata Therapeutics, Inc. (DRMA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading DRMA stock, having executed 51 transactions in the past 90 days. The most active insider is Gerald T. Proehl (Executive), who has made 13 transactions totaling $97.6K.
Related Tools
Track Dermata Therapeutics, Inc. Insider Activity
Get notified when executives and directors at DRMA file new Form 4 transactions